Open2.220 | Close2.340 |
Vol / Avg.303.345K / 564.042K | Mkt Cap122.892M |
Day Range2.190 - 2.415 | 52 Wk Range1.220 - 6.850 |
Black Diamond Therapeutic Stock (NASDAQ: BDTX) stock price, news, charts, stock research, profile.
Open2.220 | Close2.340 |
Vol / Avg.303.345K / 564.042K | Mkt Cap122.892M |
Day Range2.190 - 2.415 | 52 Wk Range1.220 - 6.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.460 | -0.450 | 0.0100 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.540 | -0.520 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-22 | HC Wainwright & Co. | Robert Burns | Reiterates | BuyBuy | Maintains | - | 11.00 |
2023-09-12 | Wedbush | Robert Driscoll | Reiterates | OutperformOutperform | Maintains | - | 10.00 |
2023-07-14 | Piper Sandler | Joseph Catanzaro | Initiates Coverage On | Overweight | Announces | - | 11.00 |
2023-06-30 | Stifel | Bradley Canino | Upgrades | HoldBuy | Raises | 2.00 | 10.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BDTX | Black Diamond Therapeutic | 9.68% | 122.9M |
ANIX | Anixa Biosciences | 0.91% | 103.8M |
VAXX | Vaxxinity | -6.08% | 110.6M |
GALT | Galectin Therapeutics | 0% | 121.2M |
CARM | CARISMA Therapeutics | -7.2% | 93.6M |
You can purchase shares of Black Diamond Therapeutic (NASDAQ: BDTX) through any online brokerage.
Other companies in Black Diamond Therapeutic’s space includes: Anixa Biosciences (NASDAQ:ANIX), Vaxxinity (NASDAQ:VAXX), Galectin Therapeutics (NASDAQ:GALT), CARISMA Therapeutics (NASDAQ:CARM) and PepGen (NASDAQ:PEPG).
The latest price target for Black Diamond Therapeutic (NASDAQ: BDTX) was reported by HC Wainwright & Co. on Wednesday, November 22, 2023. The analyst firm set a price target for 11.00 expecting BDTX to rise to within 12 months (a possible 362.18% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Black Diamond Therapeutic (NASDAQ: BDTX) is $2.38 last updated November 30, 2023 at 11:41 PM UTC.
There is no dividend information for Black Diamond Therapeutic.
Black Diamond Therapeutic’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for Black Diamond Therapeutic.
Black Diamond Therapeutic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.